Newsroom Newsroom Browse or search the latest content Featured news, opinion pieces and real-life stories 27 July 2023 News Read more MMV receives rank of “very high performer” in 2023 Global Health 50/50 report for 2nd year 11 July 2023 News Read more Malaria eradication impossible without addressing pregnancy treatment and prevention options 13 June 2023 Resource Read more Dianah's story: an expectant mother with malaria Latest films and media Films Infographics Podcasts Breaking barriers: The power of inclusive R&D to accelerate malaria elimination 24 May 2023 MMV's Chief of Corporate Strategy and Affairs Andrea Lucard spoke at "Breaking barriers: The power of inclusive R&D to accelerate malaria elimination," hosted by Devex in partnership with MMV. Partnership for Vivax Elimination (PAVE) Peru vlog 27 April 2023 A video blog from the MMV Peru team following the launch of the PAVE Peru feasibility study in March 2023. Working together to defeat malaria in pregnancy: Annual RBM Malaria in Pregnancy Working Group meeting 25 April 2023 This video showcases the 2022 RBM Malaria in Pregnancy Working Group (MiPWG) Meeting in Accra, Ghana. The MiPWG is a diverse group of stakeholders that convenes annually to share updates on progress to defeat malaria in pregnancy. The APMEN Vivax Working Group: Supporting malaria elimination in Asia-Pacific 24 April 2023 This short video explores the role of the APMEN Vivax Working Group in the fight against malaria in the Asia-Pacific region. MMV achievements in 2022 26 June 2023 Throughout 2022, MMV helped treat and protect millions of people against malaria while making significant progress in multiple key areas. See the infographic below for more details. The lifecycle of the malaria parasite 22 December 2022 Malaria parasites spread by successively infecting two types of hosts: female Anopheles mosquitoes and humans. Find out more from the infographic. Defeating malaria through complementary interventions 11 November 2022 This infographic demonstrates the necessity of using complementary interventions to control and eliminate malaria, especially among the most at-risk groups. Developing antimalarials tailored to local geography and patient needs The medicines that prevent and treat malaria should be tailored to the geographies in which they are deployed and meet the unique needs of pregnant women and the youngest patients. 10 June 2022 Culture and geography along the road to health impact It is not enough to develop medicines tailored to diverse patient needs and local context, one must ensure that the medicines reach the patients they are meant to treat. This requires unique knowledge of culture, geography and field conditions. 10 June 2022 Gender bias at the heart of medical research Pregnant women are more likely to catch diseases such as malaria and they are less likely to receive appropriate treatment. Dr Hellen Barsosio, a Kenyan researcher and medical doctor tells us more about this inequality at the heart of medical research. 4 March 2021 Latest reports MMV Annual Report 2022 Read an in-depth overview of MMV's activities and our financial statements for 2022. Keeping the Promise: Product Development Partnerships’ Role in the New Age of Health Research and Product Development PDPs remain the chief developers of innovative medical technologies for people suffering with diseases and health threats underserved by traditional markets. World Malaria Report 2022 The 2022 edition of the WHO World Malaria Report finds that, despite disruptions to prevention, diagnostic and treatment services during the pandemic, countries around the world have largely held the line against further setbacks to malaria control. See more Scientific and thematic publications MMV at a glance: towards a malaria-free world Medicines for Malaria Venture (MMV) works with partners to bring forward effective and affordable antimalarial medicines to save lives. MMV at a glance highlights our unique partnership model, the growth of our portfolio and the increasing impact of our access work. Moving seasonal malaria chemoprevention out of its geographical isolation Ganaplacide (KAF156) plus lumefantrine solid dispersion formulation combination for uncomplicated Plasmodium falciparum malaria: an open-label, multicentre, parallel-group, randomised, controlled, phase 2 trial See more Upcoming events 18 Nov GMP/MMV's Antimalarial Resistance Online Forum Starting Nov 18 2023 for 4 weeks. Join us at any time Online forum, open for all to join 27 Nov 3rd International Conference on Public Health in Africa (CPHIA 2023) 27-30 November 2023 Lusaka, Zambia 30 Nov COP 28 30 November - 12 December Dubai, United Arab Emirates 21 Apr 8th MIM Society Conference 21-27 April 2024 Kigali, Rwanda The 8th MIM Society Conference is taking place from 21-27 April 2024 at the Kigali Convention Centre in Kigali, Rwanda. Search our Search our News & press releases Stories, opinions & interviews Reports & scientific publications Films, media & audio Events
Breaking barriers: The power of inclusive R&D to accelerate malaria elimination 24 May 2023 MMV's Chief of Corporate Strategy and Affairs Andrea Lucard spoke at "Breaking barriers: The power of inclusive R&D to accelerate malaria elimination," hosted by Devex in partnership with MMV.
Partnership for Vivax Elimination (PAVE) Peru vlog 27 April 2023 A video blog from the MMV Peru team following the launch of the PAVE Peru feasibility study in March 2023.
Working together to defeat malaria in pregnancy: Annual RBM Malaria in Pregnancy Working Group meeting 25 April 2023 This video showcases the 2022 RBM Malaria in Pregnancy Working Group (MiPWG) Meeting in Accra, Ghana. The MiPWG is a diverse group of stakeholders that convenes annually to share updates on progress to defeat malaria in pregnancy.
The APMEN Vivax Working Group: Supporting malaria elimination in Asia-Pacific 24 April 2023 This short video explores the role of the APMEN Vivax Working Group in the fight against malaria in the Asia-Pacific region.
MMV achievements in 2022 26 June 2023 Throughout 2022, MMV helped treat and protect millions of people against malaria while making significant progress in multiple key areas. See the infographic below for more details.
The lifecycle of the malaria parasite 22 December 2022 Malaria parasites spread by successively infecting two types of hosts: female Anopheles mosquitoes and humans. Find out more from the infographic.
Defeating malaria through complementary interventions 11 November 2022 This infographic demonstrates the necessity of using complementary interventions to control and eliminate malaria, especially among the most at-risk groups.
Developing antimalarials tailored to local geography and patient needs The medicines that prevent and treat malaria should be tailored to the geographies in which they are deployed and meet the unique needs of pregnant women and the youngest patients. 10 June 2022
Culture and geography along the road to health impact It is not enough to develop medicines tailored to diverse patient needs and local context, one must ensure that the medicines reach the patients they are meant to treat. This requires unique knowledge of culture, geography and field conditions. 10 June 2022
Gender bias at the heart of medical research Pregnant women are more likely to catch diseases such as malaria and they are less likely to receive appropriate treatment. Dr Hellen Barsosio, a Kenyan researcher and medical doctor tells us more about this inequality at the heart of medical research. 4 March 2021
18 Nov GMP/MMV's Antimalarial Resistance Online Forum Starting Nov 18 2023 for 4 weeks. Join us at any time Online forum, open for all to join
27 Nov 3rd International Conference on Public Health in Africa (CPHIA 2023) 27-30 November 2023 Lusaka, Zambia
21 Apr 8th MIM Society Conference 21-27 April 2024 Kigali, Rwanda The 8th MIM Society Conference is taking place from 21-27 April 2024 at the Kigali Convention Centre in Kigali, Rwanda.